Improving Sleep Health in Adults With Overweight or Obesity

Sponsor
University of Pittsburgh (Other)
Overall Status
Active, not recruiting
CT.gov ID
NCT04990206
Collaborator
(none)
20
1
1
13.8
1.4

Study Details

Study Description

Brief Summary

This study will examine the feasibility and acceptability of the Transdiagnostic Intervention for Sleep and Circadian Dysfunction (TranS-C) in adults with poor sleep and excess weight. Additionally, the study will explore if TranS-C improves sleep health and cardiovascular outcomes.

Condition or Disease Intervention/Treatment Phase
  • Behavioral: TranS-C
N/A

Detailed Description

Aim 1 (Primary): Examine the feasibility and acceptability of TranS-C among adults with poor sleep health and excess weight.

Aim 2 (Exploratory): Explore the effect of TranS-C on the sleep health of adults with poor sleep and excess weight.

Aim 3 (Exploratory): Explore the effect of TranS-C on the cardiometabolic health of adults with poor sleep and excess weight.

Study Design

Study Type:
Interventional
Anticipated Enrollment :
20 participants
Allocation:
N/A
Intervention Model:
Single Group Assignment
Masking:
None (Open Label)
Primary Purpose:
Treatment
Official Title:
A Behavioral Intervention to Improve the Sleep Health of Adults With Obesity: A Feasibility and Acceptability Study
Actual Study Start Date :
Oct 7, 2021
Anticipated Primary Completion Date :
Oct 1, 2022
Anticipated Study Completion Date :
Dec 1, 2022

Arms and Interventions

Arm Intervention/Treatment
Experimental: Intervention

TranS-C

Behavioral: TranS-C
TranS-C will be provided in eight weekly, one-on-one 50-minute sessions delivered remotely by two-way video conferencing. Each week will include goal setting and homework assignments which will be reviewed in the following session. The sessions will include information on sleep and circadian rhythms, behavioral change and motivation, and goal setting. The topics covered in the sessions include establishing regular sleep-wake times, learning a wind-down route, learning a wake-up routine, improving daytime functioning, correcting unhelpful sleep-related beliefs, and maintenance of behavior change.

Outcome Measures

Primary Outcome Measures

  1. Recruitment rate [6-months]

    Percentage of potential participants screened in order to enroll 10 participants

  2. Attrition rate [6-months]

    Percentage of enrolled participants completing the 8-week intervention

  3. Completeness of questionnaire responses [6-months]

    Percentage of completed responses

Secondary Outcome Measures

  1. Change in composite sleep health score [8-weeks (baseline to post-intervention)]

    Change in composite measure of sleep health which is the sum of scores on 6 sleep dimensions. Each dimension will be dichotomized as either 'good (1)' or 'poor (0)' based on clinically and scientifically relevant rationales and added together. Score will range from 0-6 with higher scores representing better sleep health.

  2. Change in sleep regularity [8-weeks (baseline to post-intervention)]

    Change in standard deviation of actigraphic wake time.

  3. Change in sleep satisfaction [8-weeks (baseline to post-intervention)]

    Change in Pittsburgh Sleep Quality Index (PSQI) sleep quality item. Item score ranges from 'very good (0)' to 'very bad (3)'.

  4. Change in alertness [8-weeks (baseline to post-intervention)]

    Change in Epworth Sleepiness Scale (ESS). Total score ranges from 0-24. Scores equal to or greater than 10 represent excessive daytime sleepiness.

  5. Change in sleep timing [8-weeks (baseline to post-intervention)]

    Change in mean actigraphic sleep midpoint.

  6. Change in sleep efficiency [8-weeks (baseline to post-intervention)]

    Change in mean actigraphic sleep efficiency.

  7. Change in sleep duration [8-weeks (baseline to post-intervention)]

    Change in mean actigraphic sleep duration.

  8. Change in body mass index [8-weeks (baseline to post-intervention)]

    Calculated by dividing weight in pounds by height in inches squared and multiplying by a conversion factor of 703. Weight will be measured a with Tanita Scale and Body Fat Analyzer. Height will be measured in with a stadiometer.

  9. Change in systolic and diastolic blood pressure (BP) [8-weeks (baseline to post-intervention)]

    Average of two blood pressure readings at least two minutes apart.

  10. Change in waist circumference [8-weeks (baseline to post-intervention)]

    Measured with a Gulick II measuring tape above the right iliac crest. Will include two measurements to the nearest 0.1 cm. If the two values are within 2 cm of each other, a mean with be calculated; if not, the measurements will be repeated until they are within 2 cm of each other.

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • Currently own and regularly use a smart phone

  • Body mass index >27 and ≤ 43

  • Poor sleep health on one or more of the sleep health dimensions

Exclusion Criteria:
  • Presence of an unstable condition requiring physician-supervised diet and exercise

  • Physical limitations precluding ability to engage in moderate-intensity physical activity

  • Pregnant or intention to become pregnant during study

  • Current treatment for a serious mental illness

  • Being a current shift worker

  • Reported alcohol intake > 4 drinks/day for males and > 3 drinks/day for females

  • Current participation in a formal weight loss program, loss of ≥ 5% weight in past 6 months, or current use of weight loss medication

  • History of bariatric surgery

  • Planned extended vacations, absences, or relocation during study

  • Another member of household is a participant in the study

  • Score > 32 on the Eating Habits Checklist, an eating disorder scale

Contacts and Locations

Locations

Site City State Country Postal Code
1 University of Pittsburgh School of Nursing Pittsburgh Pennsylvania United States 15213

Sponsors and Collaborators

  • University of Pittsburgh

Investigators

  • Principal Investigator: Christopher C Imes, PhD, University of Pittsburgh

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Christopher Imes, Assistant Professor, University of Pittsburgh
ClinicalTrials.gov Identifier:
NCT04990206
Other Study ID Numbers:
  • STUDY21050043
First Posted:
Aug 4, 2021
Last Update Posted:
Aug 1, 2022
Last Verified:
Jul 1, 2022
Individual Participant Data (IPD) Sharing Statement:
Yes
Plan to Share IPD:
Yes
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Additional relevant MeSH terms:

Study Results

No Results Posted as of Aug 1, 2022